Results 141 to 150 of about 408,308 (200)

Insulin Growth Factor Binding Protein-6 and the Liver. [PDF]

open access: yesCells
Coda ARD   +7 more
europepmc   +1 more source

Diabetes and its complications: molecular mechanisms, prevention and treatment. [PDF]

open access: yesSignal Transduct Target Ther
Zhao L   +7 more
europepmc   +1 more source

Endocrinological aspects of sarcopenic obesity. [PDF]

open access: yesAnn Med
Minnetti M   +10 more
europepmc   +1 more source

Synthetic insulin-like growth factor II

Biochemical and Biophysical Research Communications, 1985
Human insulin-like growth factor II with 67 amino acid residues and three disulfide bridges has been synthesized by the solid-phase method. Homogeneity of the synthetic product is ascertained by chromatofocusing, high performance liquid chromatography and amino acid analysis.
C H, Li   +3 more
openaire   +2 more sources

Insulin‐Like Growth Factor II Effects Mediated through Insulin‐Like Growth Factor II Receptors

Acta Paediatrica, 1990
ABSTRACT. Insulin‐like growth factor II (IGF‐II) resembles the homologous peptide insulin‐like growth factor I (IGF‐I) in that it stimulates cellular growth in vitro. This effect is generally believed to be mediated through IGF type 1 receptors; the role of the IGF type 2 receptor remains, as yet, unknown.
M, Tally, K, Hall
openaire   +2 more sources

Insulin-Like Growth Factor II in Hepatocellular Carcinoma

Biomarkers in Medicine, 2007
Hepatocellular carcinoma is one of the most common malignant human tumors. Hepatocarcinogenesis is a multistep process with a multifactorial etiology. Chronic hepatitis B and hepatitis C virus infection, alcohol drinking and cirrhosis of any etiology are the major risk factors for hepatocellular carcinoma.
Jeng-Eing, Jeng   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy